Search

Your search keyword '"Tinker, Lesley F."' showing total 204 results

Search Constraints

Start Over You searched for: Author "Tinker, Lesley F." Remove constraint Author: "Tinker, Lesley F." Database Unpaywall Remove constraint Database: Unpaywall
204 results on '"Tinker, Lesley F."'

Search Results

1. Biomarker-assessed total energy intake and its cohort study association with all-cause mortality in postmenopausal females

2. The Women’s Health Initiative Randomized Trials and Clinical Practice

3. Genome-Wide Interaction Analysis with DASH Diet Score Identified Novel Loci for Systolic Blood Pressure

5. Correction: Distinct germline genetic susceptibility profiles identified for common non-Hodgkin lymphoma subtypes

6. Sugar-Sweetened and Artificially Sweetened Beverages and Risk of Liver Cancer and Chronic Liver Disease Mortality

7. Metabolomics-Based Biomarker for Dietary Fat and Associations with Chronic Disease Risk in Postmenopausal Women1

8. Metabolomics Biomarkers for Fatty Acid Intake and Biomarker-Calibrated Fatty Acid Associations with Chronic Disease Risk in Postmenopausal Women1

9. Total energy expenditure as assessed by doubly labeled water and all-cause mortality in a cohort of postmenopausal women

11. Data from A Prospective Targeted Serum Metabolomics Study of Pancreatic Cancer in Postmenopausal Women

12. Demographic, Health and Lifestyle Factors Associated with the Metabolome in Older Women

13. Supplementary Figure 3 from A Prospective Targeted Serum Metabolomics Study of Pancreatic Cancer in Postmenopausal Women

14. Supplementary Figure Legends from A Prospective Targeted Serum Metabolomics Study of Pancreatic Cancer in Postmenopausal Women

15. Supplementary Figure 2 from A Prospective Targeted Serum Metabolomics Study of Pancreatic Cancer in Postmenopausal Women

16. Supplementary Table 1 from A Prospective Targeted Serum Metabolomics Study of Pancreatic Cancer in Postmenopausal Women

17. Supplementary Figure 1 from A Prospective Targeted Serum Metabolomics Study of Pancreatic Cancer in Postmenopausal Women

18. Supplementary Material from A Prospective Targeted Serum Metabolomics Study of Pancreatic Cancer in Postmenopausal Women

19. Supplementary Figure 3 from A Prospective Targeted Serum Metabolomics Study of Pancreatic Cancer in Postmenopausal Women

20. Supplementary Material from A Prospective Targeted Serum Metabolomics Study of Pancreatic Cancer in Postmenopausal Women

21. Supplementary Figure 2 from A Prospective Targeted Serum Metabolomics Study of Pancreatic Cancer in Postmenopausal Women

22. Data from A Prospective Targeted Serum Metabolomics Study of Pancreatic Cancer in Postmenopausal Women

23. Supplementary Figure Legends from A Prospective Targeted Serum Metabolomics Study of Pancreatic Cancer in Postmenopausal Women

24. Supplementary Figure 1 from A Prospective Targeted Serum Metabolomics Study of Pancreatic Cancer in Postmenopausal Women

25. Supplementary Table 1 from A Prospective Targeted Serum Metabolomics Study of Pancreatic Cancer in Postmenopausal Women

27. Supplementary Figure 1 from Cancer Incidence and Mortality during the Intervention and Postintervention Periods of the Women's Health Initiative Dietary Modification Trial

28. Supplementary Table 1 from Cancer Incidence and Mortality during the Intervention and Postintervention Periods of the Women's Health Initiative Dietary Modification Trial

29. Supplementary Figure 1 from Cancer Incidence and Mortality during the Intervention and Postintervention Periods of the Women's Health Initiative Dietary Modification Trial

30. Supplementary Table 1 from Cancer Incidence and Mortality during the Intervention and Postintervention Periods of the Women's Health Initiative Dietary Modification Trial

33. Supplementary Material from Use of a Urinary Sugars Biomarker to Assess Measurement Error in Self-Reported Sugars Intake in the Nutrition and Physical Activity Assessment Study (NPAAS)

34. Supplementary Table 2 from Cancer Incidence and Mortality during the Intervention and Postintervention Periods of the Women's Health Initiative Dietary Modification Trial

35. Supplementary Table 2 from Cancer Incidence and Mortality during the Intervention and Postintervention Periods of the Women's Health Initiative Dietary Modification Trial

38. Supplementary Material from Use of a Urinary Sugars Biomarker to Assess Measurement Error in Self-Reported Sugars Intake in the Nutrition and Physical Activity Assessment Study (NPAAS)

40. Design and methodological considerations for biomarker discovery and validation in the Integrative Analysis of Lung Cancer Etiology and Risk (INTEGRAL) Program

42. Comparison of the Ketogenic Ratio of Macronutrients with the Low-Carbohydrate Diet Score and their Association with Risk of Type 2 Diabetes in Postmenopausal Women: A Secondary Analysis of the Women’s Health Initiative

43. Associations of Biomarker-Calibrated Healthy Eating Index-2010 Scores with Chronic Disease Risk and Their Dependency on Energy Intake and Body Mass Index in Postmenopausal Women

44. Mortality Associated with Healthy Eating Index Components and an Empirical-Scores Healthy Eating Index in a Cohort of Postmenopausal Women

45. Absolute Risk of Oropharyngeal Cancer After an HPV16-E6 Serology Test and Potential Implications for Screening: Results From the Human Papillomavirus Cancer Cohort Consortium

46. Distinct germline genetic susceptibility profiles identified for common non-Hodgkin lymphoma subtypes

47. The Portfolio Diet and Incident Type 2 Diabetes: Findings From the Women’s Health Initiative Prospective Cohort Study

48. The Portfolio Diet and Incident Type 2 Diabetes: Findings from the Women’s Health Initiative Prospective Cohort Study

49. The Portfolio Diet and Incident Type 2 Diabetes: Findings from the Women’s Health Initiative Prospective Cohort Study

50. Continuity of Care Among Postmenopausal Women With Cardiometabolic Diseases in the United States Early During the COVID-19 Pandemic: Findings From the Women’s Health Initiative

Catalog

Books, media, physical & digital resources